NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions supporting the entire clinical trial process, announced the launch of a ...
The ALS Therapy Development Institute (ALS TDI) has developed a tool that maps ALS clinical trials globally, using technology from Esri. Dubbed ALS Trial Navigator, the tool is designed to streamline ...
The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...
SAN FRANCISCO, June 02, 2026--(BUSINESS WIRE)--Lou Gehrig Day — EverythingALS, a nonprofit dedicated to accelerating research, technology, and patient access for amyotrophic lateral sclerosis (ALS), ...
CAMBRIDGE, Mass. and AMSTERDAM, May 7, 2012 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into a partnership with Regenesance to ...
Partners will assess Neurotune neuromuscular junction compound in ALS model. The ALS Therapy Development Institute and Neurotune established a collaboration to evaluate one of the latter’s ...
ALS Trial Navigator Offers People Living with ALS an Easy Way to Search Eligible Research Studies REDLANDS, Calif. — The ALS Therapy Development Institute ( ALS TDI), a nonprofit biotech dedicated to ...
Medidata to apply proprietary artificial intelligence tools to aid the fight against ALS New initiative is part of Medidata’s ongoing commitment to rare diseases The Medidata Institute engages and ...
This ALS-focused research will be supported by EverythingALS and Vision 2030’s $1M initial investment in the newly launched Allen Institute’s Brain Health Accelerator. The Allen Institute has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results